MON Related FDA
-
Monsanto Co. (MON) Receives Response Letter from U.S. FDA Regarding GRAS Notification
-
Monsanto (MON) Receives FDA Approval for Production of POSILAC in Georgia Facility
-
ICOR Sells Assets to MON for $6.75M; To Focus on Drug Activities
Back to MON Stock Lookup
